申请人:——
公开号:US20030232814A1
公开(公告)日:2003-12-18
Compounds of the general formula (I):
1
wherein R
1
, R
2
, R
3
and R
4
are as described in the specification.
Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament which particularly acts on the central nervous system, particularly for use as anti-obesity agents.
通式(I)的化合物:其中R1、R2、R3和R4如规范所述。此外还包括包含这些化合物的药物组合物、它们的制备过程,以及使用这些化合物制备药物,该药物特别对中枢神经系统产生作用,特别是用作抗肥胖剂。